Literature DB >> 25422738

Seizures and movement disorders induced by hyperglycemia without ketosis in elderly.

Samia Younes1, Yousra Cherif1, Mouna Aissi2, Wafa Alaya1, Olfa Berriche1, Amel Boughammoura2, Mahbouba Frih-Ayed2, Baha Zantour1, Mohamed Habib Sfar1.   

Abstract

BACKGROUND: Non-ketotic hyperglycemia (NKHG) may increase the probability of seizures and movement disorders.
METHODS: We describe a series of 14 elders admitted for seizures and movement disorders linked to NKHG.
RESULTS: Twelve patients developed motor seizures and two others movement disorders. Glucose levels varied 9.28 to 32 mmol/l, while osmolarity values varied from 302.28 to 328 mosmol/l. All patients responded well to insulin therapy and four of them needed anti-epileptic drugs.
CONCLUSION: Seizures or movement disorders in elderly with NKHG could be misdiagnosed as neurological diseases. Blood glucose must be audited whenever patients with seizures or movement disorders are encountered, as the condition may quickly resolve when NKHG is controlled.

Entities:  

Keywords:  Chorea-Ballismus; Hyperglycemia Without Ketosis; Movement Disorder; Non-Ketotic Hyperglycemia; Seizures

Year:  2014        PMID: 25422738      PMCID: PMC4240936     

Source DB:  PubMed          Journal:  Iran J Neurol        ISSN: 2008-384X


Introduction

Seizures and movement disorders related to non-ketotic hyperglycemia (NKHG) have been reported with increasing frequency since the first case documented in 1965.[1],[2] The clinical spectrum of this syndrome is various with a severe course in elderly. It develops more quickly than other disorders of diabetes mellitus with hyperglycemia, but usually without evidence of ketosis.[2],[3] Since the syndrome often ensues during the course of any illness and yet has not been reported in diverse medical fields, doctors must become familiar with this preventable condition, especially in elders. Thus, only the prompt institution of appropriate insulin therapy will improve prognosis and hasten recovery.[2],[3]

Materials and Methods

We performed a retrospective study of 14 patients referred to the Department of Internal Medicine and Endocrinology over a period of 6 years between 2006 and 2012, on the basis of clinical and biological data consistent with seizures and movement disorders related to NKHG. Our patients satisfied the inclusion criteria of NKHG: hyperglycemia with no evidence of ketosis, seizures that disappeared when hyperglycemia is controlled and the absence of lesions in cerebral imaging that may explain seizures. Exclusion criteria included a family or personal history of epilepsy, previous cranial trauma, and preexisting neurological disorders associated with seizures. All patients underwent complete physical examination and routine laboratory analyses, including blood cell count, plasma glucose, serum electrolytes, renal, and liver tests. Urine samples were tested for glucose and ketones. Blood pH was measured in the ward laboratory. Hourly monitoring of the plasma glucose was undertaken at the bedside using dextrostix. Diagnosis of NKHG was based on hyperglycemia, without ketoacidosis and no abnormalities in cerebral imaging and electroencephalogram (EEG). The appropriate amounts of physiological saline were given. Soluble insulin was injected as soon as the diagnosis was carried. The dose of intramuscular insulin was calculated upon the patient’s weight. The initial dose was 0.1 U/kg hourly until the acute symptoms had been overcome and the plasma glucose had fallen. The medical records of the patients were reviewed for follow-up and response to treatment.

Results

A total of 14 patients (6 men and 8 women) were included. The main clinical, biological findings, cerebral imaging, EEG, and treatment of the patients are summarized in table 1.
Table 1

Clinical and paraclinical details of 14 elderly patients with seizures and movement disorders related to non-ketotic hyperglycemia on admission and discharge

Age (years)/sex Duration of MD (years) Seizures and/or movement disorders Physical examination Plasma glucose (mmol/l) Osmolarity (mmol/l) Blood (pH) Plasma Na + /K + (mmol/l) Creatinin e (µmol/l) Cerebral imaging
EEG on admission/interictal Treatment Symptoms vanishing after (day) Follow-up 3 months
CT MRI
76/F14PMS in right hemi-bodyMemory disturbance31.803207.54133/3.253CSCA-ND/NDInsulin1No recurrence
77/M20GTCSN17.70319ND145/3.770N-N/NDInsulin, valproate1Recurrent seizures
73/F7PMS in right hemi-faceComa right hemiparesis20.40313ND132/4.269N-ND/fronto-temporal epileptogenic areaInsulin, valproate1No recurrence
71/F5GTCS→PSEN32.003287.47135/4.188N-N/NDInsulin4Recurrent seizures
71/M7GTCSLeft hemiparesis19.05309ND138/3.7127LS-N/NDInsulin, clonazepam3Recurrent seizures
80/F15Right versiveRight hemiparesis27.003207.44138/4.1153LSFrontal hygromaND/NDInsulin2No recurrence
79/M5PMS on right upper limb secondarily GTCSN20.853197.42133/4.5160CSCA-N/NDInsulin1No recurrence
76/F12Left hemiballismN28.803247.33132/5145LSCSCA leukoaraiosis ancient left pontine strokeND/NDInsulin4No recurrence
78/F10Left hemichoreaN19.50318ND133/4.5158CSCA, leukoaraiosis-N/NDInsulin4No recurrence
72/FPSEN14.54295.34ND140/3.865CSCA-N/NDInsulin, Valproate2No recurrence
68/FPMSN13.00305ND139/4.179N-ND/NDInsulin1No recurrence
72/MGTCSN18.60323ND138/4.275N-N/NDInsulin3No recurrence
77/MGTCSN15.08302.28ND135/4.482NCSCAN/NDInsulin2No recurrence
75/MGTCSN9.28315ND137/3.769N-N/NDInsulin, Valproate1No recurrence

MD: Mellitus diabetes; CT: Computed tomography; MRI: Magnetic resonance imaging; CSCA: Cortico-subcortical atrophy; PMS: Partial motor seizures; GTCS: Generalized tonic-clonic seizures

N: Normal; PSE: Partial status epilepticus, LS: Lacunar stroke, EEG: Electroencephalogram, ND: Not done

The female to male sex ratio was of 1.33. The mean age at the onset of seizures and movement disorders was 75 ± 3 years (71-80 years). The duration of the follow-up ranged from 1 to 31 months (Median of 9 months). The previous medical history of patients was noteworthy with diabetes mellitus in all cases and arterial hypertension in three cases. Four patients experienced partial motor seizures, which were secondarily generalized in only one case. The clinical course was complicated with a partial status epilepticus in another case. Generalized tonic-clonic seizures marked six patients. Movement disorders were present in two cases: a sudden onset of left hemiballism in one case and a left hemichorea in another case. The patients’ vital signs were stable. The blood pressure was within the normal range in all patients even suffering from arterial hypertension during hospitalization. Eight patients were conscious, and one was obtunded at admission. A thorough neurological examination was normal in 10 cases and revealed a post-critical regressive neurological hemiparesis (Todd’s paralysis) in three patients. The paraclinical data revealed elevated plasma glucose in all patients. At admission, the plasma glucose levels varied from 9.28 to 32 mmol/l with a mean level of 24.01 mmol/l, but in only five patients the blood creatinine level was over 127 µmol/l. The mean values of serum sodium, serum potassium, and plasma osmolarity were 135.44 mmol/l (132-145 mmol/l), 4.17 mmol/l (3.2-5.0 mmol/l), and 318.88 mosmol/l (302.28-328 mosmol/l), respectively. There was no evidence of ketosis in all urine samples. Blood pH, when performed, was normal or rather elevated in all cases. The electrocardiogram (ECG) monitoring showed no pronounced peaking of the T-waves at admission. In addition, computed tomography brain was normal in seven patients. In the other cases, it showed cortico-subcortical atrophy (CSCA) in four cases, and ancient lacunar strokes in three other cases. The density of ancient lacunar infract is uniform like the spinal fluid. Cerebral magnetic resonance imaging (MRI) that lacked in 11 cases, revealed a frontal lobe meningioma in case 6 and CSCA, leukoaraiosis and an ancient left pontine stroke in case 8 and CSCA in case 13 (Table 1). The interictal or ictal EEG was recorded in only 10 patients. It was often normal in nine cases or found especially rapid bilateral peaks in the frontotemporal area (Case 3). Several amounts of physiological saline were infused as a first priority to relieve dehydration at the following rates: 1000-2000 ml in 1 h, 500-1000 ml considering the severity of renal failure. Potassium chloride was added in amount 10 mmol (mEq) per 500 ml of physiological saline as soon as the first dose of insulin was given, provided the ECG showed no peaks of T-waves. All our patients were administered immediately intravenous insulin with a target dextrostix ranged between 7.5 and 10 mmol/l, to which six of them initially responded well. Monitoring of the plasma glucose was undertaken subsequently using dextrostix, and potassium deficiency was controlled every 4 h. The injections were repeated at hourly intervals until the plasma glucose had fallen below 10 mmol/l. When the acute symptoms of seizures and movement disorders relieved within a mean of 2 ± 1 day (1-4 days), intravenous insulin was withdrawn and insulin was injected subcutaneously every 4 h. Anti-epileptic drugs were prescribed during the hospital stay in one case of partial epilepticus status and in three cases of persistent and recurrent seizures despite appropriate insulin therapy. The clinical course was notable over 3 months with relapses of seizures in cases 2, 4, and 5 (Table 1). In all cases, patients were thereafter referred to the Department of Endocrinology for management of the diabetes mellitus.

Discussion

Uncontrolled hyperglycemia remains a frequent complication in old patients with diabetes mellitus. The seizures associated with NKHG are seen most often beyond the 5th decade of life[2]-[6] with the mean age of 64 years, albeit few cases have been reported in children.[2] It tends to present in female patients.[2],[4],[7] The female to male ratio remains controversial.[2] The present series is consistent with literature, with a mean age at the onset of 75 years and the female to male sex ratio was 1.33. All the patients were known as diabetics evolving since about 10 years (5-20 years). The series in the literature showed that in 50% of cases seizures initiated an unknown diabetes.[2],[3],[8] Clinical and paraclinical details of 14 elderly patients with seizures and movement disorders related to non-ketotic hyperglycemia on admission and discharge MD: Mellitus diabetes; CT: Computed tomography; MRI: Magnetic resonance imaging; CSCA: Cortico-subcortical atrophy; PMS: Partial motor seizures; GTCS: Generalized tonic-clonic seizures N: Normal; PSE: Partial status epilepticus, LS: Lacunar stroke, EEG: Electroencephalogram, ND: Not done The occurrence of seizures may also like all our patients, be a feature of diabetic decompensation in patients with known diabetes.[2],[8] In fact, a family history of diabetes or the current use of drugs, especially steroids and a previous history of polyuria, polyphagia, and polydypsia should be sought.[3] Different types of seizures were noticed.[2],[3] They are motor seizures at the rate of 75-86%,[9] usually focal,[2],[3],[8] rarely generalized tonic-clonic seizures. Seizures associated with NKHG are often recurrent, and partial status epilepticus were observed.[3],[7],[9] Other neurological manifestations are reported in the literature, such lateral hemianopia, visual hallucinations,[2],[9]-[11] cortical blindness,[12] recurrent giratory seizures[13] and chorea or hemiballism[3]-[6],[10],[14]-[22] or even scarce biballism.[5],[11],[18] Four patients of the present study experienced partial seizures (Cases 1, 3, 6 and 7), which may secondarily generalized (Only case 7). Generalized tonic-clonic seizures marked six patients. The clinical course of case 4 was complicated with a partial status epilepticus. Movement disorders were present in two cases: hemiballism in case 8 and hemichorea in case 9. The acute symptoms were most often spontaneous,[2] but they can be also triggered by motion, infection or other factors disturbing diabetes mellitus. No triggering factor was found in our patients. The physical examination may show severe dehydration. The thorough neurological examination is frequently normal[2],[3] or may find like in three of our patients a post-critical regressive neurological hemiparesis[2],[3] (Cases 3, 5, and 6). Plasma glucose largely exceeds 20 mmol/l.[2],[3],[17] Not only lower values have been reported,[3] but also higher values which are associated with severe disorders of consciousness.[2],[17] The plasma osmolarity is normal or slightly increased.[2],[3] Serum sodium is normal or low increased; however hyponatremia was described, especially in partial status epilepticus,[2],[9] unlike our patient. Serum ketosis is absent or present but in trace amounts.[2] Hyperglycemia ranged from 9.28 to 32 mmol/l in our series. Hyponatremia was found in five of our patients and the serum osmolarity did not exceed 328 mosmol/l. The MRI is usually normal,[2],[3],[5],[9] but it may reveal cerebral abnormalities such as hyperintensity involving the striatum,[5],[10],[15],[19] the putamen,[4],[18],[19],[23] the caudate and Globus pallidus[4],[18],[19] and rarely subthalamic nucleus lesion.[19],[20] The existence of an abnormality suggests an underlying focal lesion.[2],[8],[17] In our series, cerebral imaging revealed abnormalities that were not related to the occurrence of seizures or movement disorders. It revealed CSCA in six cases and lacunar strokes in three other cases. Indeed, the abnormality may disappear after stabilization of hyperglycemia and even so the movement disorder or seizures did not resolve.[23] The EEG may be normal like most of our cases.[2],[9] It may be a prime investigation especially in visual hallucinations and homonymous hemianopia.[9],[10] The interictal abnormalities were most often found in the frontal,[2] more rarely temporal or occipital areas.[9],[10] The interictal EEG of case 3 showed frontotemporal localized peaks. The differential diagnosis of NKHG might be excluded.[18],[22],[23] First, seizures may occur in diabetic patients as a result of severe renal and hepatic failure, cerebral stroke, drug intoxication or any other etiology in the non-diabetic subject.[13],[18],[23] The accurate pathogenesis of seizures and movement disorders related to NKHG remains still unclear. Currently, multiple factors, such as vascular lesions, local brain damage, and metabolic factors may contribute to this condition. It partially involves hyperglycemia.[2],[16] In addition, hyperglycemia increases the metabolism of gamma-aminobutyric acid, and then reduces the threshold of seizures.[2],[4],[9],[14]-[16] Hyponatremia sometimes seems to worsen seizures secondary to NKHG. Singh et al.[7] showed that partial status epilepticus had been protracted in cases of associated hyponatremia with NKHG. Few studies performed brain spectroscopy and revealed the decrease in N-acetyl aspartate and the brain glucose metabolism[4],[6],[9],[10],[14],[15],[18],[19],[21],[24] in seizures as far as in chorea. In both brain biopsies of the putamen of two patients showed necrotic foci surrounded by significant gliosis, with prominent infiltration of gemistocytic astrocytes.[4],[10],[13],[21],[25] Recently, brain needle biopsy has revealed obliterative vasculopathy with prominent vascular proliferation.[3],[14],[25] Pisani et al. results provide the first evidence that an unrecognized acanthocytosis in diabetes might bring NKHG.[26] The symptoms are typically refractory to antiepileptic drugs but respond well to insulin therapy.[2],[3],[13] Nonetheless, it requires sometimes the antiepileptic and neuroleptic drugs in movement disorders.[2],[3],[5],[6],[17],[22] The antiepileptic drugs especially phenytoin may be harmful and inhibit the insulin secretion.[2],[8] In our series, the anti-epileptic drugs were prescribed in four patients and have in most cases quickly achieved a satisfactory improvement. Clonazepam was prescribed in emergency settings to treat severe recurrent seizures that may disclose to status epilepticus. When seizures were typically spaced in time, we prescribed the sodium valproate. These antiepileptic drugs were thereafter withdrawn. However, three of patients have recurrent seizures for longer than 3 months, although it is typically much milder than at presentation. Atypical cases have been reported with delayed onset after resolution of the hyperglycemia, unremitting severe disorder movements, and late recurrence.[4],[5],[22],[25] The prognosis of seizures and movement disorders related to NKHG has been reported to be excellent,[2],[3],[8],[13]-[15] and it was indeed excellent in our all patients too. Nevertheless, Kaseda et al. reported a case of recurrent hemichorea for longer than 1 year in whom they applied 10 daily sessions of low-frequency repetitive transcranial magnetic stimulation over the cortical lesion to reduce the hyperexcitability and get rid of movement disorder.[14] There are two limitations of our study, first is the limited sample size of elders and secondly, the short follow-up and further implications were not assessed. We did not compare our results to the younger population. Then, at present, we are unable to predict if elderly are more vulnerable to develop NKHG.

Conclusion

The association of recent onset of seizures with NKHG is striking. Prompt treatment would substantially improve the outcomes of NKHG and avoid the use of antiepileptic drugs and their potential harm in elderly with major comorbidities. Although the appropriate therapy must be started, the search for a focal lesion should be pursued especially in old polymedicated patients. Thereby, we believe that familiarity with seizures and movement disorders related to NKHG will help in questing the differential diagnosis without delay. These cases suggest that acute NKHG should not be delayed as a possible etiology of chorea-ballismus and seizures in elderly, given that diabetes is usually longstanding and poorly controlled and the variable response of elderly diabetics to insulin therapy.
  26 in total

1.  Hemiballism with hyperglycemia and striatal T1-MRI hyperintensity: an autopsy report.

Authors:  S Ohara; S Nakagawa; K Tabata; T Hashimoto
Journal:  Mov Disord       Date:  2001-05       Impact factor: 10.338

2.  FOCAL SEIZURES AS A MANIFESTATION OF HYPERGLYCEMIA WITHOUT KETOACIDOSIS. A REPORT OF SEVEN CASES WITH REVIEW OF THE LITERATURE.

Authors:  M MACCARIO; C P MESSIS; E F VASTOLA
Journal:  Neurology       Date:  1965-03       Impact factor: 9.910

3.  Magnetic resonance spectroscopy findings in a case of hyperglycaemic hemianopia.

Authors:  A Guez; M Obadia; F Lafitte; S Nwing Tin; F Héran; O Gout
Journal:  Rev Neurol (Paris)       Date:  2010-03-10       Impact factor: 2.607

4.  Focal seizures and non-ketotic hyperglycaemia.

Authors:  A Hennis; D Corbin; H Fraser
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

5.  [Epileptic seizures in non-ketotic hyperglycemia].

Authors:  T Lammouchi; F Zoghlami; L Ben Slamia; M Grira; M S Harzallah; S Benammou
Journal:  Neurophysiol Clin       Date:  2004-10       Impact factor: 3.734

6.  Chorea-ballismus in acute non-ketotic hyperglycaemia.

Authors:  H El Otmani; F Moutaouakil; H Fadel; N El Ouafi; M Abdoh Rafai; B El Moutaouakil; I Slassi
Journal:  Funct Neurol       Date:  2009 Jul-Sep

7.  Unilateral putaminal CT, MR, and diffusion abnormalities secondary to nonketotic hyperglycemia in the setting of acute neurologic symptoms mimicking stroke.

Authors:  Max Wintermark; Nancy J Fischbein; Pratik Mukherjee; Esther L Yuh; William P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

8.  Hemichorea-hemiballism: an explanation for MR signal changes.

Authors:  D E Shan; D M Ho; C Chang; H C Pan; M M Teng
Journal:  AJNR Am J Neuroradiol       Date:  1998-05       Impact factor: 3.825

Review 9.  Hemiballism-hemichorea and non-ketotic hyperglycaemia.

Authors:  J J Lin; M K Chang
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-06       Impact factor: 10.154

10.  Amelioration of persistent, non-ketotic hyperglycemia-induced hemichorea by repetitive transcranial magnetic stimulation.

Authors:  Yumiko Kaseda; Takemori Yamawaki; Junko Ikeda; Miwa Hayata; Eisuke Dohi; Tomohiko Ohshita; Kazuhide Ochi; Eiichi Nomura; Masayasu Matsumoto
Journal:  Case Rep Neurol       Date:  2013-03-29
View more
  5 in total

1.  Hyperglycemia reduces functional expression of astrocytic Kir4.1 channels and glial glutamate uptake.

Authors:  D E Rivera-Aponte; M P Méndez-González; A F Rivera-Pagán; Y V Kucheryavykh; L Y Kucheryavykh; S N Skatchkov; M J Eaton
Journal:  Neuroscience       Date:  2015-09-25       Impact factor: 3.590

2.  Recurrent Facial Focal Seizures With Chronic Striatopathy and Caudate Atrophy-A Double Whammy in an Elderly Woman With Diabetes Mellitus.

Authors:  Subhankar Chatterjee; Ritwik Ghosh; Umesh Kumar Ojha; Payel Biswas; Julián Benito-León; Souvik Dubey
Journal:  Neurohospitalist       Date:  2021-07-23

3.  Hyperglycemia-induced seizures - Understanding the clinico- radiological association.

Authors:  Shivaprakash B Hiremath; Amol A Gautam; Prince J George; Agnes Thomas; Reji Thomas; Geena Benjamin
Journal:  Indian J Radiol Imaging       Date:  2019-12-31

4.  Downregulation of Astrocytic Kir4.1 Potassium Channels Is Associated with Hippocampal Neuronal Hyperexcitability in Type 2 Diabetic Mice.

Authors:  Miguel P Méndez-González; David E Rivera-Aponte; Jan Benedikt; Geronimo Maldonado-Martínez; Flavia Tejeda-Bayron; Serguei N Skatchkov; Misty J Eaton
Journal:  Brain Sci       Date:  2020-01-30

5.  Is diabetic striatopathy the culprit of seizures in a patient with ketotic hyperglycemia-induced hemichorea-hemiballismus?

Authors:  Abeer Sabry Safan; Omna Sharma; Muna Almasri; Ashton Ian D'Souza; Omer Suliman
Journal:  BMC Neurol       Date:  2022-04-08       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.